Novartis Invests $23B in US, Opens Cancer Drug Plant
Update: 2025-11-11
Description
Novartis unveils new cancer drug manufacturing plant in California, marking a significant step in its $23 billion U.S. expansion. The facility focuses on radioligand therapy, a precision medicine that targets cancerous tumors, and is the companys third such production site in the U.S. Novartis also plans to establish additional radioligand therapy manufacturing facilities in Florida and Texas, and a second global research and development hub in San Diego. This expansion comes amidst political and regulatory pressure on pharmaceutical companies to reduce drug prices and increase domestic production.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
